Skip to main content
. 2020 Sep 3;20(5):191. doi: 10.3892/ol.2020.12053

Figure 1.

Figure 1.

Expression of miR-25 and miR-365 in the experimental and control groups of NSCLC patients. (A) The expression of miR-25 of the patients in the experimental group. qRT-PCR revealed that the relative expression level of miR-25 of the patients in the experimental group was significantly higher than that of the patients in the control group. (B) The expression of miR-365 of the patients in the experimental group. qRT-PCR revealed that relative expression level of miR-365 of the patients in the experimental group was significantly lower than that of the patients in the control group. *P<0.05 vs. the control group.